Aggregation and properties of α-synuclein and related proteins

被引:3
作者
El-Agnaf, OMA
Irvine, GB
机构
[1] Univ Lancaster, Div Biol Sci, Lancaster LA1 4YQ, England
[2] Queens Univ Belfast, Ctr Med Biol, Sch Biol & Biochem, Ctr Peptide & Prot Engn, Belfast BT9 7BL, Antrim, North Ireland
来源
SPECTROSCOPY-AN INTERNATIONAL JOURNAL | 2001年 / 15卷 / 3-4期
关键词
alpha-Synuclein; non-A beta-component (NAC); Parkinson's disease; amyloid; fibrils;
D O I
10.1155/2001/939274
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Synuclein has been identified as a component of intracellular fibrillar protein deposits in several neurodegenerative diseases, and two mutant forms have been associated with early onset Parkinson's disease. A fragment of alpha-synuclein has also been identified as the non-Abeta component of Alzheimer's disease amyloid (NAC). Ageing solutions of alpha-synuclein and NAC leads to formation of beta-sheet, detectable by circular dichroism spectroscopy, and aggregation to form amyloid-like fibrils, detectable by electron microscopy. Differences in the rates of aggregation of the fibrils formed by alpha-synuclein and the two mutant proteins are presented. The toxicity of alpha-synuclein and related peptides towards neurons is also discussing in relation to the aetiology of neurodegenerative diseases. Experiments on fragments of NAC have enabled the region of NAC responsible for its aggregation and toxicity to be identified.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 60 条
  • [1] Ubiquitin, cellular inclusions and their role in neurodegeneration
    Alves-Rodrigues, A
    Gregori, L
    Figueiredo-Pereira, ME
    [J]. TRENDS IN NEUROSCIENCES, 1998, 21 (12) : 516 - 520
  • [2] α-Synuclein-positive structures in cases with sporadic Alzheimer's disease:: morphology and its relationship to tau aggregation
    Arai, Y
    Yamazaki, M
    Mori, O
    Muramatsu, H
    Asano, G
    Katayama, Y
    [J]. BRAIN RESEARCH, 2001, 888 (02) : 287 - 296
  • [3] Baba M, 1998, AM J PATHOL, V152, P879
  • [4] α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque cores
    Bayer, TA
    Jäkälä, P
    Hartmann, T
    Havas, L
    McLean, C
    Culvenor, JG
    Li, QX
    Masters, CL
    Falkai, P
    Beyreuther, K
    [J]. NEUROSCIENCE LETTERS, 1999, 266 (03) : 213 - 216
  • [5] Degradation of α-synuclein by proteasome
    Bennett, MC
    Bishop, JF
    Leng, Y
    Chock, PB
    Chase, TN
    Mouradian, MM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) : 33855 - 33858
  • [6] Parkinson's disease-associated α-sylnuclein is more fibrillogenic than β- and γ-synuclein and cannot cross-seed its homologs
    Biere, AL
    Wood, SJ
    Wypych, J
    Steavenson, S
    Jiang, YJ
    Anafi, D
    Jacobsen, FW
    Jarosinski, MA
    Wu, GM
    Louis, JC
    Martin, F
    Narhi, LO
    Citron, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) : 34574 - 34579
  • [7] Toxicity of non-Aβ component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of β-sheet structure and fibrils
    Bodles, AM
    Guthrie, DJS
    Harriott, P
    Campbell, P
    Irvine, GB
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (08): : 2186 - 2194
  • [8] Identification of the region of non-Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity
    Bodles, AM
    Guthrie, DJS
    Greer, B
    Irvine, GB
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 78 (02) : 384 - 395
  • [9] Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
    Borghi, R
    Marchese, R
    Negro, A
    Marinelli, L
    Forloni, G
    Zaccheo, D
    Abbruzzese, G
    Tabaton, M
    [J]. NEUROSCIENCE LETTERS, 2000, 287 (01) : 65 - 67
  • [10] Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO